Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB-WT) Operating Leases (2023 - 2025)

Nuvation Bio (NUVB-WT) has disclosed Operating Leases for 3 consecutive years, with $2.5 million as the latest value for Q4 2025.

  • Quarterly Operating Leases rose 162.44% to $2.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Dec 2025, up 162.44% year-over-year, with the annual reading at $2.5 million for FY2025, 162.44% up from the prior year.
  • Operating Leases for Q4 2025 was $2.5 million at Nuvation Bio, down from $3.0 million in the prior quarter.
  • The five-year high for Operating Leases was $3.8 million in Q1 2025, with the low at $969000.0 in Q4 2024.
  • Average Operating Leases over 3 years is $2.2 million, with a median of $2.5 million recorded in 2023.
  • The sharpest move saw Operating Leases crashed 61.36% in 2024, then surged 249.69% in 2025.
  • Over 3 years, Operating Leases stood at $2.0 million in 2023, then plummeted by 52.38% to $969000.0 in 2024, then skyrocketed by 162.44% to $2.5 million in 2025.
  • According to Business Quant data, Operating Leases over the past three periods came in at $2.5 million, $3.0 million, and $3.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.